The relationship of molecular genetic to clinical diagnosis of familial hypercholesterolemia in a Danish population.
暂无分享,去创建一个
O. Faergeman | M. L. Larsen | J. Jensen | Mogens L Larsen | Ole Faergeman | Jesper M Jensen | P. Nissen | Dorte Damgaard | Peter H Nissen | Henrik K Jensen | Vibeke R Soerensen | Lillian G Jensen | H. Jensen | D. Damgaard | L. Jensen | V. Soerensen | M. Larsen
[1] T. Miettinen,et al. Diagnosis of heterozygous familial hypercholesterolemia. DNA analysis complements clinical examination and analysis of serum lipid levels. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.
[2] R. Levy,et al. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.
[3] S. Humphries,et al. Comparison of the risk of fatal coronary heart disease in treated xanthomatous and non-xanthomatous heterozygous familial hypercholesterolaemia: a prospective registry study. , 2003, Atherosclerosis.
[4] S. Humphries,et al. A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia. , 2003, Atherosclerosis.
[5] M. Brown,et al. Familial hypercholesterolemia: identification of a defect in the regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity associated with overproduction of cholesterol. , 1973, Proceedings of the National Academy of Sciences of the United States of America.
[6] J. Kastelein,et al. The molecular basis of familial hypercholesterolemia in The Netherlands , 2001, Human Genetics.
[7] Jonathan D. Cohen,et al. Monogenic hypercholesterolemia: new insights in pathogenesis and treatment. , 2003, The Journal of clinical investigation.
[8] I. Young,et al. A novel single base deletion in the LDLR gene (211delG): Effect on serum lipid profiles and the influence of other genetic polymorphisms in the ACE, APOE and APOB genes. , 1996, Atherosclerosis.
[9] H. Jensen,et al. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark. , 2002, Danish medical bulletin.
[10] M. Leppert,et al. Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics. , 1993, The American journal of cardiology.
[11] R. Westendorp,et al. Additional risk factors influence excess mortality in heterozygous familial hypercholesterolaemia. , 2000, Atherosclerosis.
[12] O. Faergeman,et al. High sensitivity of the single-strand conformation polymorphism method for detecting sequence variations in the low-density lipoprotein receptor gene validated by DNA sequencing. , 1996, Clinical chemistry.
[13] S. Humphries,et al. Genetic testing for familial hypercholesterolaemia: practical and ethical issues. , 1997, QJM : monthly journal of the Association of Physicians.
[14] R. Krauss,et al. Familial defective apolipoprotein B-100: a mutation of apolipoprotein B that causes hypercholesterolemia. , 1990, Journal of lipid research.
[15] L. Bolund,et al. Normolipidemia and hypercholesterolemia in persons heterozygous for the same 1592+5G→A splice site mutation in the low‐density lipoprotein receptor gene , 1999, Clinical genetics.
[16] M. Skolnick,et al. A mutation in PCSK9 causing autosomal-dominant hypercholesterolemia in a Utah pedigree , 2004, Human Genetics.
[17] G. Coetzee,et al. Characterization of six patients who are double heterozygotes for familial hypercholesterolemia and familial defective apo B-100. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.
[18] J. Kastelein,et al. Results from a family and DNA based active identification programme for familial hypercholesterolaemia , 2001, Journal of epidemiology and community health.
[19] E. Sijbrands,et al. Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands , 2001, The Lancet.
[20] D. Zwijnenburg,et al. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. , 2002, Nucleic acids research.
[21] J. Weissenbach,et al. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia , 2003, Nature Genetics.
[22] D. Blankenhorn,et al. The inheritance of familial hypercholesterolemia. , 1972, The American journal of medicine.
[23] O. Faergeman,et al. Spectrum of LDL receptor gene mutations in Denmark: implications for molecular diagnostic strategy in heterozygous familial hypercholesterolemia. , 1999, Atherosclerosis.
[24] O. Faergeman,et al. Detection of the apoB-3500 mutation (glutamine for arginine) by gene amplification and cleavage with MspI. , 1991, Journal of lipid research.
[25] S. Humphries,et al. A molecular genetic service for diagnosing individuals with familial hypercholesterolaemia (FH) in the United Kingdom , 2001, European Journal of Human Genetics.